1. Home
  2. Stock quotes
  3. Brainstorm Cell Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Brainstorm Cell Therapeutics logo
Brainstorm Cell Therapeutics BCLI
$ 2.26 8.73%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Brainstorm Cell Therapeutics EV/EBITDA Ratio 2011-2024 | BCLI

Annual EV/EBITDA Ratio Brainstorm Cell Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-5.59 -4.78 -3.83 -5.21 -13.3 -10.1 -5.28 -6.77 -7.97 -8.62 -6.55

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-3.83 -13.3 -7.09